Updated Jul 16, 2026
Milligan Michael Lee is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $5K.
Michael Lee Milligan is identified in SEC filings as a corporate insider associated with Neumora Therapeutics, Inc. (NMRA) under CIK 0001993953, with the most recent filing dated 2026-01-09. The filing record indicates zero insider purchases or sales, and does not disclose a specific executive title for him in the provided context.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-19 | NMRA | Neumora Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.4K | $3.56 | $5K |
Michael Lee Milligan is identified in SEC filings as a corporate insider associated with Neumora Therapeutics, Inc. (NMRA) under CIK 0001993953, with the most recent filing dated 2026-01-09. The filing record indicates zero insider purchases or sales, and does not disclose a specific executive title for him in the provided context.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($5K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Milligan Michael Lee profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.